- £37.57m
- £38.20m
- £55.01m
- 63
- 25
- 42
- 36
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 42.1 | 48.2 | 39.4 | 48.7 | 55 |
Cost of Revenue | |||||
Gross Profit | 33.9 | 38.6 | 34.4 | 42.4 | 48.7 |
Selling / General / Administrative Expenses | |||||
Total Operating Expenses | 37 | 40.8 | 39.6 | 49 | 51.9 |
Operating Profit | 5.13 | 7.42 | -0.219 | -0.349 | 3.08 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 5.13 | 7.4 | -0.356 | -0.482 | 2.96 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3.95 | 5.91 | -0.232 | 1.6 | 2.94 |
Net Income Before Extraordinary Items | |||||
Net Income | 3.95 | 5.91 | -0.232 | 1.6 | 2.94 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 3.95 | 5.91 | -0.232 | 1.6 | 2.94 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.066 | 0.053 | 0.002 | 0.016 | 0.028 |
Dividends per Share |